MedPath

The effect of oral simvastatin on the outcome of patients with severe traumatic brain injury

Phase 3
Conditions
Severe traumatic brain injury.
Registration Number
IRCT20180802040668N1
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
98
Inclusion Criteria

Patients with severe traumatic brain injury
Non-use of corticosteroids and statins and NSAIDs
Not having an allergy to statins
Not having a history of autoimmune, cardio, respiratory, neuromuscular, liver or kidney disease

Exclusion Criteria

Space-occupying lesion in the skull, including hematoma and ...
GCS higher than 8 or GCS = 3 on admission
Age> 60 and <18 years
Syndrome organ trauma that requires surgical intervention.
trauma of the limbs that requires surgical intervention.
History of poisoning or drug use
sepsis during the first 72 hours of admission

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
GCS, APACHEE2, ISS. Timepoint: The beginning of the study, Day 3 and Day 10 after starting treatment. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath